Calabrò V, Mason P J, Filosa S, Civitelli D, Cittadella R, Tagarelli A, Martini G, Brancati C, Luzzatto L
Department of Haematology, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.
Am J Hum Genet. 1993 Mar;52(3):527-36.
We have carried out a systematic study of the molecular basis of glucose-6-phosphate dehydrogenase (G6PD) deficiency on a sample of 53 male subjects from Calabria, in southern Italy. Our sequential approach consisted of the following steps: (1) Partial biochemical characterization was used to pinpoint candidate known variants. The identity of these was then verified by restriction-enzyme or allele-specific oligonucleotide hybridization analysis of the appropriate PCR-amplified fragment. (2) On samples for which there was no obvious candidate mutation, we proceeded to amplify the entire coding region in eight fragments, followed by single-strand conformation polymorphism (SSCP) analysis of each fragment. (3) The next step was M13 phage cloning and sequencing of those individual fragments that were found to be abnormal by SSCP. Through this approach we have identified the molecular lesion in 51 of the 53 samples. In these we found a total of nine different G6PD-deficient variants, five of which (G6PD Mediterranean, G6PD A-, G6PD Coimbra, G6PD Seattle, and G6PD Montalbano) were already known, whereas four are new (G6PD Cassano, G6PD Cosenza, G6PD Sibari, and G6PD Maewo). G6PD Mediterranean is the commonest variant, followed by G6PD Seattle. At least seven of the variants are present, at polymorphic frequencies, in the Calabria region, and some have a nonrandom distribution within the region. This study shows that the genetic heterogeneity of G6PD deficiency in Calabria, when analyzed at the DNA level, is even greater than had been anticipated from biochemical characterization. The sequential approach that we have followed is fast and efficient and could be applied to other populations.
我们对来自意大利南部卡拉布里亚的53名男性受试者样本进行了葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症分子基础的系统研究。我们的序贯方法包括以下步骤:(1)进行部分生化特征分析以确定已知候选变体。然后通过对适当的PCR扩增片段进行限制性内切酶或等位基因特异性寡核苷酸杂交分析来验证其身份。(2)对于没有明显候选突变的样本,我们将整个编码区扩增为八个片段,随后对每个片段进行单链构象多态性(SSCP)分析。(3)下一步是对那些经SSCP分析发现异常的单个片段进行M13噬菌体克隆和测序。通过这种方法,我们在53个样本中的51个中鉴定出了分子病变。在这些样本中,我们总共发现了九种不同的G6PD缺乏变体,其中五种(G6PD地中海型、G6PD A-型、G6PD科英布拉型、G6PD西雅图型和G6PD蒙塔尔巴诺型)是已知的,而四种是新的(G6PD卡萨诺型、G6PD科森扎型、G6PD锡巴里型和G6PD马埃沃型)。G6PD地中海型是最常见的变体,其次是G6PD西雅图型。至少有七种变体以多态频率存在于卡拉布里亚地区,并且有些在该地区内具有非随机分布。这项研究表明,在DNA水平上分析时,卡拉布里亚G6PD缺乏症的遗传异质性甚至比生化特征预期的还要大。我们采用的序贯方法快速且高效,可应用于其他人群。